NEA Management Company, LLC 13F Holdings · Q2 2026
NEA Management Company, LLC reported 26 securities worth $1.59B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: TRVI (15.53%), MBX (12.56%), GLUE (11.72%). Among its top 25 positions this quarter: 1 new, 2 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TRVI | Trevi Therapeutics, Inc. | $246.6M | 15.53% | 13.2M | Hold |
| 2 | MBX | MBX Biosciences, Inc. | $199.5M | 12.56% | 3.6M | Hold |
| 3 | GLUE | Monte Rosa Therapeutics, Inc. | $186.2M | 11.72% | 7.7M | Hold |
| 4 | CELC | Celcuity Inc. | $179.0M | 11.27% | 1.7M | Trimmed |
| 5 | SGP | Spyglass Pharma, Inc. | $164.6M | 10.36% | 7.4M | Hold |
| 6 | SVRA | Savara, Inc. | $150.7M | 9.49% | 24.5M | Hold |
| 7 | ZBIO | Zenas BioPharma, Inc. | $102.1M | 6.43% | 4.0M | Hold |
| 8 | COUR | Coursera, Inc. | $72.6M | 4.57% | 12.9M | Hold |
| 9 | AUPH | Aurinia Pharmaceuticals, Inc. | $67.4M | 4.24% | 4.0M | Hold |
| 10 | CRSP | CRISPR Therapeutics AG | $57.7M | 3.64% | 1.1M | Hold |
| 11 | ORIC | ORIC Pharmaceuticals, Inc. | $44.6M | 2.81% | 4.1M | Hold |
| 12 | PHAT | Phathom Pharmaceuticals, Inc. | $21.3M | 1.34% | 2.0M | Hold |
| 13 | KRRO | Korro Bio, Inc. | $17.1M | 1.08% | 1.3M | Hold |
| 14 | XFOR | X4 Pharmaceuticals, Inc. | $15.1M | 0.95% | 3.2M | Hold |
| 15 | CSBR | Champions Oncology, Inc. | $10.6M | 0.66% | 1.7M | Hold |
| 16 | NKTX | Nkarta, Inc. | $10.1M | 0.64% | 3.6M | Hold |
| 17 | CVRX | CVRx, Inc. | $10.0M | 0.63% | 2.0M | Trimmed |
| 18 | BDTX | Black Diamond Therapeutics, Inc. | $8.2M | 0.52% | 4.4M | Hold |
| 19 | IVA | Inventiva SA | $5.5M | 0.35% | 1.5M | Hold |
| 20 | KPTI | Karyopharm Therapeutics Inc. | $5.6M | 0.35% | 576,780 | New |
| 21 | LONA | LeonaBio, Inc. | $4.3M | 0.27% | 464,398 | Hold |
| 22 | SNTI | Senti Biosciences, Inc. | $4.2M | 0.26% | 3.8M | Hold |
| 23 | MRKR | Marker Therapeutics, Inc. | $2.4M | 0.15% | 1.6M | Hold |
| 24 | OKUR | OnKure Therapeutics, Inc. | $2.2M | 0.14% | 478,548 | Hold |
| 25 | IMA | ImageneBio, Inc. | $295,030 | 0.02% | 50,005 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR